Europe Automated Breast Ultrasound Systems (ABUS) Market to Cross USD 328 Million By 2024

March 25, 2020


As per the report titled ‘Europe Automated Breast Ultrasound Systems (ABUS) Market Size By Product, End-Use , Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024’ available with Market Study Report LLC, Europe automated breast ultrasound systems (ABUS) is projected to accrue USD 328 million by the year 2024.
 

Rising focus towards breast cancer screening coupled with increasing initiatives promoting breast cancer awareness is augmenting automated breast ultrasound systems market outlook in Europe. Initiatives such as Breast Cancer Screening Program (BCSP) in Russia which offers screening at 2-year intervals to women aged 40 to 60 years will boost the adoption of ABUS devices in the forthcoming years.
 

Ineffectiveness of mammography systems to detect cancer in dense breast tissue will shift consumer inclination towards ABUS. It aids in the detection of small tumors at early stage of breast cancer, thereby reducing the treatment cost. This factor coupled with superior screening and detection ability as compared to mammography systems is fostering the demand for automated imaging modalities, hence stimulating market growth. However, high cost of ABUS devices and poor reimbursement conditions will restrict the market share over the forecast timeline.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2505945/
 

Based on the product, the market is categorized into automated breast ultrasound system (ABUS), automated breast volume scanners (ABVS), and others. The former segment amassed USD 51.1 million in 2017 and is expected to see considerable growth during the forecast timeline. Rising customer preference owing to high detection efficiency is stimulating the product demand. Enhanced view of breast and shorter image generation periods are the key benefits, encouraging the product adoption.
 

Regionally, France ABUS market is presumed to expand with a CAGR of 12.9% during 2018-2024. Increasing cases of breast cancer along with rising initiatives towards promotion of breast cancer screening such free national screening for women aged 50 to 74, are supporting the regional business outlook.
 

Major players of Europe automated breast ultrasound systems market are CapeRay Medical Ltd., GE Healthcare, Delphinus Medical Technologies, Hitachi Ltd., Metritrack, Inc., Koninklijke Philips N.V., Nova Medical Imaging Technology Co. Ltd., Real Imaging, QView Medical Inc., and Seno Medical Instruments Inc., among others.


Frequently Asked Questions (FAQ) :

Rising focus towards breast cancer screening coupled with increasing initiatives promoting breast cancer awareness is augmenting the demand for automated breast ultrasound systems in Europe.
The high cost of ABUS devices and poor reimbursement conditions may hinder the market growth in the coming years.
Increasing cases of breast cancer along with rising initiatives towards promotion of breast cancer screening such free national screening for women aged 50 to 74, are supporting France business outlook.
Market majors are CapeRay Medical Ltd., GE Healthcare, Delphinus Medical Technologies, Hitachi Ltd., Metritrack, Inc., Koninklijke Philips N.V., and Nova Medical Imaging Technology Co. Ltd. among others.